Kanghong Pharmaceutical fell 0.20% today, with a stock price of 35.52 yuan, a transaction amount of 182 million yuan, a transaction of 50,000 lots, and a turnover rate of 0.83%.
Dolphin Stock APP trading line trend analysis: is currently in an upward trend, and the short-term trend is stronger than the market. Consolidate in volume and pay attention to trend changes.
: Net inflow on that day -44.82 million, and net inflow on the past three days -64.46 million.
Company's main business: The company's main business is the research and development, production and sales of drugs (including biological products, Chinese patent medicines, chemical drugs) and medical devices (mainly ophthalmic medical devices).
As of September 30, 2019, Kanghong Pharmaceutical's operating income was 2.41 billion yuan, an increase of 10.41% year-on-year, and net profit attributable to parent company shareholders was 552 million yuan, an increase of 9.05% year-on-year.
Click to download the Dolphin Stock APP, and the smart market-oriented free experience for life
Disclaimer: All content on this page is for investors' reference only and does not constitute any investment advice.
